Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02147769 · ClinicalTrials.gov registry record
Cerebral Oxygenation and Autoregulation in Preterm Infants
A clinical trial, sponsored by Stanford University.
- Completed
- Registry status
- 111
- Enrollment target
NCT02147769: Completed study, sponsored by Stanford University.
NCT02147769 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 111 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02147769 has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 111 participants
- Enrollment target
Study Summary
Premature infants are at high risk for variations in blood pressure and oxygenation during the first few days of life. The immaturity of the premature brain may further predispose these infants to death or the development of neurologic problems. The relationship between unstable blood pressure and oxygen levels and brain injury has not been well elucidated. This study investigates the utility of near-infrared spectroscopy (NIRS), a non-invasive oxygen-measuring device, to identify preterm infants at highest risk for brain injury or death.
Primary Outcome
Participants will be followed for the outcome of death prior to hospital discharge.
Interventions
- DEVICE NIRS monitoring
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 111 participants |
| Start Date | 2014-05 |
| Est. Completion | 2018-03 |
What the finished NCT02147769 record still lists
NCT02147769 is an observational study that tracks outcomes without assigning an intervention. The registered 111 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which NIRS monitoring is the first listed.
NCT02147769 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02147769 about?
NCT02147769 is a clinical study titled "Cerebral Oxygenation and Autoregulation in Preterm Infants". Premature infants are at high risk for variations in blood pressure and oxygenation during the first few days of life. The immaturity of the premature brain may further predispose these infants to death or the development of neurologic problems. The relationship between unstable blood pressure and o...
What is the current status of trial NCT02147769?
This trial is currently completed. The enrollment target is 111 participants. The study started on 2014-05. Estimated completion is 2018-03.
What interventions are being tested in trial NCT02147769?
The interventions under investigation include: NIRS monitoring (DEVICE).
Who is sponsoring clinical trial NCT02147769?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03875716 · 111 participants · NA
Study of De_Intensified Postoperative Radiation Therapy for HPV Associated Oropharyngeal Squamous Cell Carcinoma
- NCT04693468 · 111 participants · Phase 1
Talazoparib and Palbociclib, Axitinib, or Crizotinib for the Treatment of Advanced or Metastatic Solid Tumors, TalaCom Trial
- NCT05263050 · 111 participants · Phase 2
Trial of an Alternative Cabozantinib Dosing Schedule in Metastatic Renal Cell Carcinoma and Neuroendocrine Tumors
- NCT05600842 · 111 participants
De-escalated Radiation for Human Papillomavirus-Positive Squamous Cell Carcinoma of the Oropharynx
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia